Extended-Release Drugs Market Report 2026
Download Free Sample Buy Now
Extended-Release Drugs Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Extended-Release Drugs Market Report 2026

Global Outlook – By Type (Sustained Release Drug, Controlled Release Drug), By Mode (Over-The-Counter, Prescription), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Extended-Release Drugs Market Overview

• Extended-Release Drugs market size has reached to $69.63 billion in 2025

• Expected to grow to $126.89 billion in 2030 at a compound annual growth rate (CAGR) of 13%

• Growth Driver: Rising Chronic Conditions Is A Catalyst For Growth In The Extended-Release Drug Market

• Market Trend: Extended-Release Tablets For Enhanced Treatment Of Huntington Disease-Related Movement Disorders

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Extended-Release Drugs Market?

Extended-release drugs are a dosage form made to release the medication over a longer time, at a predetermined rate, duration, and location, in a controlled manner. The drug can be taken less frequently than the immediate release form, and patients may take 1 to 2 doses each day instead of 3 to 4.

The main types of extended-release drugs are sustained-release drugs and controlled-release drugs. Sustained release drug refers to medication that is intended to slowly release in the body over time, primarily to maintain therapeutic levels. They are available as over-the-counter and prescription modes and distributed by hospital pharmacies, retail pharmacies, mail-order pharmacies, and drug store channels.

Extended-Release Drugs Market Global Report 2026 Market Report bar graph

What Is The Extended-Release Drugs Market Size and Share 2026?

The extended-release drugs market size has grown rapidly in recent years. It will grow from $69.63 billion in 2025 to $77.92 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, demand for patient-centric drug formulations, limitations of immediate-release drugs, increasing healthcare expenditure, advancements in pharmaceutical excipients.

What Is The Extended-Release Drugs Market Growth Forecast?

The extended-release drugs market size is expected to see rapid growth in the next few years. It will grow to $126.89 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to growth of precision medicine, increasing adoption of oral controlled-release formulations, expansion of hospital and retail pharmacies, rising geriatric population, investment in novel delivery technologies. Major trends in the forecast period include personalized dosage regimens, advanced drug delivery systems, patient adherence optimization, novel formulation technologies, extended-release combination therapies.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Extended-Release Drugs Market Segmentation

1) By Type: Sustained Release Drug, Controlled Release Drug

2) By Mode: Over-The-Counter, Prescription

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores

Subsegments:

1) By Sustained Release Drug: Matrix Systems, Coating Systems

2) By Controlled Release Drug: Osmotic Systems, Microencapsulation Systems, Targeted Delivery Systems

What Is The Driver Of The Extended-Release Drugs Market?

The increasing incidence of chronic conditions is expected to propel the growth of the extended-release drug market going forward. Chronic conditions are defined as conditions that last for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. Heart disease, cancer, obesity, and diabetes are a few examples. Extended-release drug delivery systems are designed to provide a relatively constant level of medication in the body over a long period. It helps maintain a consistent therapeutic effect and avoids the fluctuations in drug levels that can occur with immediate-release medications. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising to 142.66 million. Therefore, the increasing incidence of chronic conditions is driving the growth of the extended-release drug industry.

Key Players In The Global Extended-Release Drugs Market

Major companies operating in the extended-release drugs market are Pfizer Inc., AbbVie Inc., Novartis AG, Sanofi SA, GlaxoSmithKline PLC, AstraZeneca Plc, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Purdue Pharma LP, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Mallinckrodt LLC, Allergan plc, Janssen Pharmaceuticals Inc., Noven Pharmaceuticals Inc., Mayne Pharma Group Ltd., Neos Therapeutics Inc., Oakwood Laboratories LLC, Roxane Laboratories Inc., Watson Pharmaceuticals Inc.

Global Extended-Release Drugs Market Trends and Insights

Major companies operating in the extended-release drugs market are developing innovative products such as next-generation extended-release tablets to enhance product offerings and gain a competitive advantage. Extended-release tablets are a type of pharmaceutical formulation designed to release their active ingredients gradually over an extended period. For instance, in February 2023, Teva Pharmaceutical Industries Ltd. an Israel-based pharmaceutical company received approval from the U.S. Food and Drug Administration (FDA) for austedo XR (deutetrabenazine). Austedo XR is recommended for the treatment of adults with chorea and tardive dyskinesia related to Huntington disease. They come in dosages of 6, 12, and 24 mg. With the approval of austedo XR, patients with tardive dyskinesia and Huntington disease chorea now have another efficient treatment option. This allows individuals to live with these disorders and the medication is administered once daily. The development of austedo XR, which provides a practical and efficient therapeutic alternative for those with certain movement disorders, signifies a significant leap in the management of these ailments.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Extended-Release Drugs Market?

In April 2024, ProMed Pharma, a US-based provider of polymer-based drug-releasing dosage forms and combination device components, acquired SpineThera’s manufacturing operational assets for an undisclosed amount. With this acquisition, ProMed Pharma aims to expand its technological capabilities in sustained- and extended-release drug formulation by integrating SpineThera’s biodegradable microsphere manufacturing platform. SpineThera is a US-based clinical-stage pharmaceutical company developing novel extended-release injectable therapies using its proprietary micro-suspension technology.

Regional Insights

North America was the largest region in the extended-release drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Extended-Release Drugs Market?

The extended-release drug market consists of sales of extended-release tablets, extended-release capsules, and implants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Extended-Release Drugs Market Report 2026?

The extended-release drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the extended-release drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Extended-Release Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $77.92 billion
Revenue Forecast In 2035 $126.89 billion
Growth Rate CAGR of 11.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Mode, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., AbbVie Inc., Novartis AG, Sanofi SA, GlaxoSmithKline PLC, AstraZeneca Plc, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Purdue Pharma LP, Amnea
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Extended-Release Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Extended-Release Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Extended-Release Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Extended-Release Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Personalized Dosage Regimens

4.2.2 Advanced Drug Delivery Systems

4.2.3 Patient Adherence Optimization

4.2.4 Novel Formulation Technologies

4.2.5 Extended-Release Combination Therapies

5. Extended-Release Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Retail Pharmacies

5.3 Clinics

5.4 Mail-Order Pharmacies

5.5 Patients

6. Extended-Release Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Extended-Release Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Extended-Release Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Extended-Release Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Extended-Release Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Extended-Release Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Extended-Release Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Extended-Release Drugs Market Segmentation

9.1. Global Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sustained Release Drug, Controlled Release Drug

9.2. Global Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Over-The-Counter, Prescription

9.3. Global Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores

9.4. Global Extended-Release Drugs Market, Sub-Segmentation Of Sustained Release Drug, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Matrix Systems, Coating Systems

9.5. Global Extended-Release Drugs Market, Sub-Segmentation Of Controlled Release Drug, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Osmotic Systems, Microencapsulation Systems, Targeted Delivery Systems

10. Extended-Release Drugs Market Regional And Country Analysis

10.1. Global Extended-Release Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Extended-Release Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Extended-Release Drugs Market

11.1. Asia-Pacific Extended-Release Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Extended-Release Drugs Market

12.1. China Extended-Release Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Extended-Release Drugs Market

13.1. India Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Extended-Release Drugs Market

14.1. Japan Extended-Release Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Extended-Release Drugs Market

15.1. Australia Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Extended-Release Drugs Market

16.1. Indonesia Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Extended-Release Drugs Market

17.1. South Korea Extended-Release Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Extended-Release Drugs Market

18.1. Taiwan Extended-Release Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Extended-Release Drugs Market

19.1. South East Asia Extended-Release Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Extended-Release Drugs Market

20.1. Western Europe Extended-Release Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Extended-Release Drugs Market

21.1. UK Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Extended-Release Drugs Market

22.1. Germany Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Extended-Release Drugs Market

23.1. France Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Extended-Release Drugs Market

24.1. Italy Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Extended-Release Drugs Market

25.1. Spain Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Extended-Release Drugs Market

26.1. Eastern Europe Extended-Release Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Extended-Release Drugs Market

27.1. Russia Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Extended-Release Drugs Market

28.1. North America Extended-Release Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Extended-Release Drugs Market

29.1. USA Extended-Release Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Extended-Release Drugs Market

30.1. Canada Extended-Release Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Extended-Release Drugs Market

31.1. South America Extended-Release Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Extended-Release Drugs Market

32.1. Brazil Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Extended-Release Drugs Market

33.1. Middle East Extended-Release Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Extended-Release Drugs Market

34.1. Africa Extended-Release Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Extended-Release Drugs Market, Segmentation By Type, Segmentation By Mode, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Extended-Release Drugs Market Regulatory and Investment Landscape

36. Extended-Release Drugs Market Competitive Landscape And Company Profiles

36.1. Extended-Release Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Extended-Release Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Extended-Release Drugs Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

37. Extended-Release Drugs Market Other Major And Innovative Companies

AstraZeneca Plc, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Purdue Pharma LP, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Mallinckrodt LLC, Allergan plc, Janssen Pharmaceuticals Inc., Noven Pharmaceuticals Inc., Mayne Pharma Group Ltd., Neos Therapeutics Inc.

38. Global Extended-Release Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Extended-Release Drugs Market

40. Extended-Release Drugs Market High Potential Countries, Segments and Strategies

40.1 Extended-Release Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Extended-Release Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Extended-Release Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Extended-Release Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Extended-Release Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Extended-Release Drugs Market, Supply Chain Analysis
  • Table 4: Global Extended-Release Drugs Market, Major Raw Material Providers
  • Table 5: Global Extended-Release Drugs Market, Major Resource Providers
  • Table 6: Global Extended-Release Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Extended-Release Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Extended-Release Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Extended-Release Drugs Market, Major Trends
  • Table 10: Global Extended-Release Drugs Market, Major End Users
  • Table 11: Global Extended-Release Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Extended-Release Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Extended-Release Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Extended-Release Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Extended-Release Drugs Market, Sub-Segmentation Of Sustained Release Drug, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Extended-Release Drugs Market, Sub-Segmentation Of Controlled Release Drug, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Extended-Release Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Extended-Release Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Extended-Release Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Extended-Release Drugs Market - Company Scoring Matrix
  • Table 96: Pfizer Inc. Financial Performance
  • Table 97: AbbVie Inc. Financial Performance
  • Table 98: Novartis AG Financial Performance
  • Table 99: Sanofi SA Financial Performance
  • Table 100: GlaxoSmithKline PLC Financial Performance
  • Table 101: Global Extended-Release Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Extended-Release Drugs Market, Competitive Dashboard
  • Table 103: Global Extended-Release Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Extended-Release Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, Extended-Release Drugs Market Size Gain ($ Billion), Segmentation By Mode, 2025 – 2030
  • Table 106: Global, Extended-Release Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Extended-Release Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Extended-Release Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Extended-Release Drugs Market, Supply Chain Analysis
  • Figure 4: Global Extended-Release Drugs Market, Major Raw Material Providers
  • Figure 5: Global Extended-Release Drugs Market, Major Resource Providers
  • Figure 6: Global Extended-Release Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Extended-Release Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Extended-Release Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Extended-Release Drugs Market, Major Trends
  • Figure 10: Global Extended-Release Drugs Market, Major End Users
  • Figure 11: Global Extended-Release Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Extended-Release Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Extended-Release Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Extended-Release Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Extended-Release Drugs Market, Sub-Segmentation Of Sustained Release Drug, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Extended-Release Drugs Market, Sub-Segmentation Of Controlled Release Drug, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Extended-Release Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Extended-Release Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Extended-Release Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Extended-Release Drugs Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Extended-Release Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Extended-Release Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Extended-Release Drugs Market - Company Scoring Matrix
  • Figure 96: Pfizer Inc. Financial Performance
  • Figure 97: AbbVie Inc. Financial Performance
  • Figure 98: Novartis AG Financial Performance
  • Figure 99: Sanofi SA Financial Performance
  • Figure 100: GlaxoSmithKline PLC Financial Performance
  • Figure 101: Global Extended-Release Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Extended-Release Drugs Market, Competitive Dashboard
  • Figure 103: Global Extended-Release Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Extended-Release Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, Extended-Release Drugs Market Size Gain ($ Billion), Segmentation By Mode, 2025 – 2030
  • Figure 106: Global, Extended-Release Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Dental Sleep Medicine Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Dental Sleep Medicine Growth Trajectory: Key Forecasts and Strategic Insights

Dipeptide Peptidase 4 Inhibitors Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Dipeptide Peptidase 4 Inhibitors Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Dipeptide Peptidase 4 Inhibitors Market Landscape: Advancements In Epilepsy Treatment Solutions By Leading Pharmaceutical Companies

Read More About Emerging Trends Redefining the Dipeptide Peptidase 4 Inhibitors Market Landscape: Advancements In Epilepsy Treatment Solutions By Leading Pharmaceutical Companies

Top Trends Driving Innovation and Change in the Gastroparesis Drugs Market: Development Of Innovative Gastroparesis Treatment

Read More About Top Trends Driving Innovation and Change in the Gastroparesis Drugs Market: Development Of Innovative Gastroparesis Treatment

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Hospitality Property Management Software Market Report 2026 - Global Outlook – By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium Enterprises), By Application (Business Hotels, R...

Mango Market Report 2026 - Global Outlook – By Type (Whole Fruit, Mango Pulp And Puree, Processed Mango Products), By Nature (Conventional, Organic), By Packaging Type (Bag, Pouches, Tray, Box, Other Packaging Types), By...

Aerospace Valves Market Report 2026 - Global Outlook – By Type (Butterfly Valves, Rotary Valves, Solenoid Valves, Flapper-Nozzle Valves, Poppet Valves, Ball Valves, Other Types), By Material (Stainless Steel, Titanium, A...

Drug Delivery Devices Market Report 2026 - Global Outlook – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Deliv...

Drug Delivery Devices Market Report 2026 - Global Outlook – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Deliv...

Injectable Drug Delivery Devices Market Report 2026 - Global Outlook – By Type (Syringes, Injectors, Pump), By Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory...

Automotive Roof System Market Report 2026 - Global Outlook – By Type (Sunroof System, Panorama Roof System, Multi-Optional Roof System, Solar Roof System, Light Weight Roof System, Inbuilt Roof System, Other Types), By M...

Basal Cell Carcinoma Treatment Market Report 2026 - Global Outlook – By Treatment (Surgery, Medication, Other Treatments), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Ch...

Frequently Asked Questions

The Extended-Release Drugs market was valued at $69.63 billion in 2025, increased to $77.92 billion in 2026, and is projected to reach $126.89 billion by 2030.

The global Extended-Release Drugs market is expected to grow at a CAGR of 13.0% from 2026 to 2035 to reach $126.89 billion by 2035.

Some Key Players in the Extended-Release Drugs market Include, Pfizer Inc., AbbVie Inc., Novartis AG, Sanofi SA, GlaxoSmithKline PLC, AstraZeneca Plc, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals In

Major trend in this market includes: Extended-Release Tablets For Enhanced Treatment Of Huntington Disease-Related Movement Disorders. For further insights on this market. request a sample here

North America was the largest region in the extended-release drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the extended-release drugs market report are Asia-Pac

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us